Is Decision Diagnostics Corp. (DECN) a Buy, Sell, or Hold?
OTC : DECN
Decision Diagnostics Corp.
$0.0001 USD
$0 (0.0%)
- Volume
- 2M
- Average Volume
- 1.71M
- Market Capitalization
- $35.79K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.33
Company Overview
OTC
Keith Berman
Medical - Pharmaceuticals
Healthcare
DECN
6
US
USD
Liquidity Metrics
6.05
0.33
0.30
0.11
0.00
Sales & Valuation
$1.98M
0.02
0.06
-0.03
-0.01
Profitability
-$0.11
-$29.67M
-1499.05%
-1499.05%
-10388.57%
-524.76%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-22.72
3/9
-$3.88M
$5.34M
$5.4M
-$2.1M
Key Metrics (TTM)
$2.44M
1.23
-1.01
0.33
-10388.57%
-57.78%
-111300.51%
-3925.93%
-206 days
Company Executives
| Name | Title |
|---|---|
| Keith Berman | Chief Executive Officer, Chief Financial Officer, Secretary & Director |
Poll Results
No votes yet today — be the first to share your view!
About Decision Diagnostics Corp. (OTC:DECN) Stock
Decision Diagnostics Corp. (DECN), founded in 2000 and based in Westlake Village, California, specializes in developing electronic medical record (EMR) technologies primarily optimized for smartphones. The company provides a wide array of offerings, including both regulated and unregulated diagnostic solutions, as well as home-use testing products for individuals managing chronic illnesses. They also facilitate direct-to-patient logistics for diabetes programs and concentrate on creating mobile-centric e-health products and associated technological innovations. A key part of their product line involves glucose monitoring. This includes the GenUltimate! glucose test strips, classified as a Class II medical device for personal at-home human use. For animal health, they manufacture PetSure! g ... lucose test strips, designed to measure glucose levels in dogs and cats and compatible with legacy Zoetis AlphaTrak glucometers. Additionally, they offer the proprietary GenUltimate! 4Pets Glucose system, which combines the GenUltimate! 4Pets strip with the Avantage meter, enabling glucose testing for canine, feline, and equine patients. Further glucose strip options include GenUltimate! Sure and GenUltimate! Precis. Beyond product development, Decision Diagnostics actively acquires and maintains a portfolio of intellectual property, spanning patents, trademarks, and specialized manufacturing equipment. Their software solutions include MD@Hand, a comprehensive management system for both inpatient and outpatient care; Practice Probe, a data mining utility designed to extract information from physician practice management systems; and ResidenceWare, a residential management system that streamlines communication between commercial or residential real estate managers and their tenants through networked applications. Ultimately, their EMR innovations provide crucial tools for physicians directly at the point of patient care. The company was originally known as InstaCare Corp. before officially changing its name to Decision Diagnostics Corp. in November 2011.
Frequently Asked Questions
-
What is the current Decision Diagnostics Corp. (DECN) stock price?
-
Decision Diagnostics Corp.(OTC:DECN) stock price is $0.0001 in the last trading session. During the trading session, DECN stock reached the peak price of $0.0001 while $0.0001 was the lowest point it dropped to. The percentage change in DECN stock occurred in the recent session was 0.0% while the dollar amount for the price change in DECN stock was $0.
-
DECN's industry and sector of operation?
-
The OTC listed DECN is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.
-
Who are the executives of DECN?
-
Keith Berman | Chief Executive Officer, Chief Financial Officer, Secretary & Director
|
|
|
| -
How many employees does DECN have?
-
Number of DECN employees currently stands at 6. DECN operates from 2660 Townsgate Road, Westlake Village, CA 91361, US.
-
Link for DECN official website?
-
Official Website of DECN is: https://www.decisiondiagnostics.com
-
How do I contact DECN?
-
DECN could be contacted at phone #805 446 1973 and can also be accessed through its website. DECN operates from 2660 Townsgate Road, Westlake Village, CA 91361, US.
-
How many shares of DECN are traded daily?
-
The average number of DECN shares traded daily for last 3 months was 1.71M.
-
What is the market cap of DECN currently?
-
The market value of DECN currently stands at $35.79K with its latest stock price at $0.0001